Eli Lilly and Company
Anti-Dkk-1-anti-RANKL bispecific antibody compounds

Abstract:

Bispecific antibody compounds, and methods of using same, are provided which bind and neutralize Dkk-1 and RANKL and which are useful as adjuncts to spinal fusion surgery or as agents for bone healing or treating conditions associated with bone loss or degeneration.